Synthetic route to anti-viral agents
US-9809576-B1 · Nov 7, 2017 · US
US10125083B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10125083-B2 |
| Application number | US-201515309013-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 5, 2015 |
| Priority date | May 9, 2014 |
| Publication date | Nov 13, 2018 |
| Grant date | Nov 13, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention concerns a method for producing diaryl carbonates from monophenols and phosgene or chloroformic acid aryl esters in the presence of an optionally substituted pyridine or the hydrochloride salt thereof as catalyst, and the recovery and reinjection thereof back into the method. The method is carried out at least partially in a liquid phase without the use of an additional solvent, the catalyst being separated by means of crystallization and recovered.
Opening claim text (preview).
The invention claimed is: 1. A process for preparing diaryl carbonate comprising: a) reacting a monophenol with phosgene and/or at least one aryl chloroformate in the presence of at least one optionally substituted pyridine, in free form and/or in the form of a hydrochloride salt thereof, as catalyst, wherein the reaction is carried out in a reactor under pressures of 1-50 bar, b) transferring the reaction mixture from the reactor into an apparatus configured for suspension crystallization, c) lowering the temperature in the apparatus, thereby introducing the suspension crystallization and forming a crystallizate, d) separating the crystallizate from the remaining catalyst-containing mother liquor, and e) at least partially recirculating the catalyst-containing mother liquor into the reactor at step a). 2. The process as claimed in claim 1 , wherein the monophenol comprises phenol. 3. The process as claimed in claim 1 , wherein not more than 10 mol % of the optionally substituted pyridine is present in free form. 4. The process as claimed in claim 3 , wherein the catalyst comprises pyridine hydrochloride. 5. The process as claimed in claim 1 , wherein an aqueous solution is not used in any of the steps a) to e). 6. The process as claimed in claim 1 , wherein hydrogen chloride formed in step a) is not neutralized. 7. The process as claimed in claim 1 , wherein hydrogen chloride formed in step a) is separated off by distillation. 8. The process as claimed in claim 1 , wherein the ratio of monophenol to diaryl carbonate is set before step c) by a thermal separation process. 9. The process as claimed in claim 1 , wherein the ratio of monophenol to diaryl carbonate in step c) is at least 0.5:1. 10. The process as claimed in claim 1 , wherein seed crystals are used in step c). 11. The process as claimed in claim 1 , wherein the temperature is reduced to below 70° C. in step c). 12. The process as claimed in claim 1 , further comprising washing crystals separated off in step d) with monophenol or a monophenol/diaryl carbonate mixture. 13. The process as claimed in claim 1 , wherein the crystallizate comprises an adduct of monophenol and diaryl carbonate. 14. The process as claimed in claim 13 , wherein the diaryl carbonate and monophenol is obtained from the adduct crystals. 15. The process as claimed in claim 1 , wherein not more than 1 mol % of the optionally substituted pyridine is present in free form. 16. The process as claimed in claim 1 , wherein the at least one monophenol consists essentially of phenol. 17. The process as claimed in claim 3 , wherein the catalyst consists essentially of pyridine hydrochloride. 18. The process as claimed in claim 1 , wherein the ratio of monophenol to diaryl carbonate in step c) is at least 1:1. 19. The process as claimed in claim 1 , wherein the ratio of monophenol to diaryl carbonate in step c) is at least 1.5:1. 20. The process as claimed in claim 1 , wherein the temperature is reduced to below 60° C. in step c).
also containing elements or functional groups covered by B01J31/0201 - B01J31/0231 · CPC title
from phosgene or haloformates · CPC title
Purification; Separation; Stabilisation · CPC title
Recycling of unreacted starting or intermediate materials · CPC title
Materials · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.